跳到正文
OurGMP· 荀令君18·AI 评分62

清洁验证分组法最差情况产品选择标准第4部分 液体、小分子API和生物技术蛋白质

清洁验证最差情况产品选择标准 – 第4部分

AI 导读

清洁《备忘录》第4部分按液体、小分子API和生物技术蛋白质,分别说明分组法清洁验证中最差情况产品的选择思路。液体制剂若活性成分属最低溶解度类别则选该产品,否则可用活性浓度、最低PDE或生产频次等打破平局;小分子API宜在同一溶剂和清洁温度下比较溶解度,生物技术蛋白质可借助SDS-PAGE比较降解时间来评估。文中同时提出,分组法中最难清洁产品的方案应采用组内最低残留限度(如L3)。

正文

Worst-Case Product Selection Criteria – Part 4
最差情况产品选择标准 – 第4部分

Dec 2023/2023年12月

This is the fourth of several Cleaning Memos dealing with the selection of a worst-case product in a grouping approach for cleaning validation.
这是关于清洁验证中采用分组法选择最差情况产品的若干《清洁备忘录》中的第四篇。

In August, we considered use of the pharmacopeia solubility categories, and also presented what may be a more useful system based on how “solubility bands” are defined.
在8月,我们考虑了药典溶解度分类的使用,并提出了一个可能更有用的系统,该系统基于如何定义“溶解度区间”。

In September, we considered issues in the use of typical evaluation systems involving calculation of a risk score that includes a solubility parameter in addition to other parameters such as toxicity, potency, and operator cleaning difficulty.
在9月,我们考虑了使用典型评估系统时的问题,这些系统涉及风险评分计算,除其他参数如毒性、效价和操作人员清洁难度外,还包括溶解度参数。

In October, we discussed solid oral drug products based on two formulation parameters (solubility and concentration of each formulation component).
在10月,我们基于两个制剂参数(每种制剂组分的溶解度和浓度)讨论了固体口服药品。

If you haven’t done so, please review those before continuing.
如果你还没有这样做,请先回顾这些内容再继续。

What follows are separate considerations for liquids, for small molecule APIs, and for biotech proteins.
以下分别针对液体、小分子API和生物技术蛋白质进行考虑。

Liquids
液体

We’ll start this month by addressing liquid formulations, specifically liquids that are aqueous and where the excipients in the formulation are readily water soluble (such as soluble at least by the USP category “slightly soluble“).
本月我们将从液体制剂开始,具体是水性液体,且制剂中的辅料易溶于水(例如至少达到USP“微溶”类别)。

For these liquid formulations, it is not necessary to consider the intensive evaluations that were covered last month for solid drug products.
对于这些液体制剂,不必考虑上个月针对固体药品所涵盖的深入评估。

For those solid products, a calculation was done to establish the “Total % Insolubles” (as defined last month) to determine the “most difficult to clean” drug product.
对于那些固体产品,进行了计算以建立“总不溶物%”(如上月定义),从而确定“最难清洁”的药品。

For these liquids, there are two possibilities.
对于这些液体,有两种可能性。

Possibility 1: One or more of the drug products has an active in the “practically insoluble” or the “very slightly soluble” category.
可能性1: 一种或多种药品的活性成分属于“几乎不溶”或“极微溶”类别。

This is likely to occur if some liquids are “true” solutions and other liquids are “suspensions”.
如果一些液体是“真”溶液,而另一些液体是“混悬液”,这很可能发生。

In this situation, if there is only one product with an active in the lowest solubility category, that product is considered the “worst case”, and that product is chosen as the “representative” product in a grouping validation protocol approach.
在这种情况下,如果只有一个产品的活性成分属于最低溶解度类别,则该产品被视为“最差情况”,并选择该产品作为分组验证方案方法中的“代表性”产品。

If two or more products fall into the same solubility category, one option is to use the criteria discussed in Example B in the October Cleaning Memo.
如果两个或更多产品属于同一溶解度类别,一种选择是使用10月《清洁备忘录》示例B中讨论的标准。

That is, to “break the tie,” move to a second parameter such as concentration of the active in the formulation.
也就是说,为了“打破平局”,转向第二个参数,如制剂中活性成分的浓度。

Another option to “break the tie” is to move from solubility categories to specific water solubility data (such as data in mg/L or ppm).
另一种“打破平局”的选择是从溶解度类别转向具体水溶解度数据(如以mg/L或ppm表示的数据)。

If such data exists for a reliable comparison, the active with the lower solubility is the worst case.
如果存在此类数据可用于可靠比较,则溶解度较低的活性成分即为最差情况。

Possibility 2: None of the drug products has an active in the “practically insoluble” or the “very slightly soluble” category.
可能性2: 没有任何药品的活性成分属于“几乎不溶”或“极微溶”类别。

This is more likely if all products are true solutions.
如果所有产品都是真溶液,这更可能。

In this case, realize that picking the “most difficult to clean” product is like asking, “How many angels can dance on the point of a pin?”
在这种情况下,要认识到选择“最难清洁”的产品就像问:“针尖上能有多少天使跳舞?”

Does it really matter, or can anyone really know?
这真的重要吗,或者真的有人能知道吗?

However, just to “formalize” the decision-making process, one option would just to pick the product with the lowest solubility category (even though it is not “practically insoluble” or “very slightly soluble”).
然而,只是为了“形式化”决策过程,一种选择是直接选择溶解度类别最低的产品(即使它不是“几乎不溶”或“极微溶”)。

A second option would be to pick the product with the highest concentration of active.
第二种选择是选择活性成分浓度最高的产品。

Additional considerations include lowest PDE active, or even the product most frequently made (to facilitate getting the validation runs performed in a timely manner).
其他考虑因素包括最低PDE的活性成分,甚至是生产最频繁的产品(以便及时完成验证运行)。

On the other hand, there may be formulations that are creams or ointments.
另一方面,可能存在乳膏或软膏制剂。

In that case, consideration of the total formulation ingredients (as done for solids) may be appropriate.
在这种情况下,考虑总制剂成分(如对固体所做的那样)可能是合适的。

However, because of the possible complexity of the cleaning process, it may be better to move to a laboratory evaluation as a more reliable way to determine the relative “difficulty of cleaning”.
然而,由于清洁过程可能复杂,最好转向实验室评估,作为确定相对“清洁难度”的更可靠方法。

Small molecule APIs
小分子API

Now we’ll “switch gears” and look at what can be done for small molecule API synthesis.
现在我们将“换挡”,看看小分子API合成可以做什么。

In that situation, it is necessary to address whether there are process materials (in addition to the API itself) that may affect the difficulty of cleaning.
在这种情况下,有必要处理是否存在可能影响清洁难度的工艺物料(除API本身外)。

Examples of such materials include charcoal and metal catalysts.
此类物料的例子包括活性炭和金属催化剂。

If it is solely the API that is of concern, and if the different APIs are cleaned with the same solvent, then it is possible to just compare the solubility of the different APIs in that one solvent at the temperature of the cleaning process.
如果仅关注API,并且不同API用相同溶剂清洁,那么可以仅比较不同API在该一种溶剂中、清洁过程温度下的溶解度。

Note, in this case, it probably is not appropriate to compare different APIs if different cleaning solvents are used.
注意,在这种情况下,如果使用不同的清洁溶剂,可能不适合比较不同API。

Part of the reason is that an “apples to apples” comparison is difficult; any difference in the temperature of cleaning (at the solvent reflux, for example) further complicates the comparison.
部分原因是“同类比较”很困难;清洁温度的任何差异(例如在溶剂回流时)会进一步使比较复杂化。

Use of different solvents also violates an essential principle for product grouping – that the products in the group be cleaned by the same cleaning procedure.
使用不同溶剂还违反了产品分组的一项基本原则——组内产品应由相同清洁程序清洁。

If “other” insoluble materials are present and if those same insoluble “other” materials are present in all products in the group at the same level, then it may be possible to look at the API solubility to determine the worst case.
如果存在“其他”不溶物料,并且这些相同的不可溶“其他”物料以相同水平存在于组内所有产品中,则可能可以查看API溶解度来确定最差情况。

If different insoluble materials are present or the insoluble “other” materials are present at different levels, then it probably complicates the situation such that it is likely that a laboratory test procedure would be the easiest way to determine difficulty of cleaning.
如果存在不同的不溶物料,或不溶“其他”物料以不同水平存在,那么情况可能复杂化,以至于实验室测试程序可能是确定清洁难度的最容易方法。

Biotech proteins
生物技术蛋白质

A final consideration for special cases involves biotech protein drugs.
特殊情况的最后一个考虑涉及生物技术蛋白质药物。

In this case, we should realize that the most important issue may be the time for degradation of the protein to form readily soluble smaller fragments.
在这种情况下,我们应认识到最重要的问题可能是蛋白质降解形成易溶较小片段所需的时间。

It may be possible to select a worst case based on a laboratory evaluation (using an end point via SDS-PAGE comparison) for different proteins, stressing the time element to determine which is the slowest in achieving “complete” degradation.
可能可以基于对不同蛋白质的实验室评估(使用SDS-PAGE比较作为终点)来选择最差情况,强调时间因素以确定哪个达到“完全”降解最慢。

This laboratory evaluation should consider equivalent cleaning procedure parameters, including the ratio of protein to cleaning solution.
该实验室评估应考虑等效的清洁程序参数,包括蛋白质与清洁溶液的比例。

On the other hand, since the equipment used may vary from protein to protein, the better option may be to just stay with an approach of doing cleaning validation separately on each product manufactured.
另一方面,由于所用设备可能因蛋白质不同而异,更好的选择可能是坚持对每个生产产品分别进行清洁验证的方法。

This concludes this series on selecting the “worst-case” products in a grouping strategy.
这结束了关于在分组策略中选择“最差情况”产品的系列。

It should be obvious that in all situations, the selection process depends to a significant degree on a manufacturer knowing and understanding its products and its cleaning procedures.
应当很明显,在所有情况下,选择过程在很大程度上取决于生产商了解和理解其产品及其清洁程序。

Furthermore, I would be remiss if I did not also say that in a grouping approach, the protocol for the “most difficult to clean” product should have a residue limit that is the lowest limit (such as L3) of any product in the group.
此外,如果我不说以下这一点,就是失职:在分组法中,“最难清洁”产品的方案应具有组内任何产品的最低残留限度(如L3)。

来源:OurGMP · mp.weixin.qq.com